Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin’s lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial

Department of Hematology, Hopital Cochin, Paris
Department of biostatistics, LYSARC, LYON
Department of Hematology-Transplantation, CHU de Bordeaux, Pessac
Department of hemato-Oncology, Hôpital St Louis, Paris
Department of Hematology, CHU de Nantes, Nantes
Department of Onco-Hématology, Institut Paoli-Calmettes, Marseille
Department of Hematology, CHU Pontchaillou, Rennes
Department of Hematology, CHU Toulouse, Toulouse
Department of Hematology, Centre Henri Becquerel, Rouen
Department of Hematology, CHU CAEN, CAEN
Department of Hematology, CHU Lille, Lille
Department of Hematology, CHU UCL Namur – Site Godinne, Yvoir
Department of Hematology, Hospices Civils de Lyon, Hopital Lyon Sud, Claude Bernard Lyon-1 University, Pierre-Bénite
Department of Pathology, Hospices Civils de Lyon, Hopital Lyon Sud, Claude Bernard Lyon-1 University, Pierre-Bénite
Department of Hematology, CHU Dijon, Dijon
Department of Hematology, CHU de Nantes, Nantes
Haematologica Early view Aug 13, 2026 https://doi.org/10.3324/haematol.2026.301194

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2026.301194
 
Published
2026-08-13
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
33
PDF Downloads
4
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online